Corinna Hahn‐Ast

738 total citations
22 papers, 492 citations indexed

About

Corinna Hahn‐Ast is a scholar working on Oncology, Hematology and Infectious Diseases. According to data from OpenAlex, Corinna Hahn‐Ast has authored 22 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Hematology and 6 papers in Infectious Diseases. Recurrent topics in Corinna Hahn‐Ast's work include Neutropenia and Cancer Infections (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Cancer Treatment and Pharmacology (6 papers). Corinna Hahn‐Ast is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Cancer Treatment and Pharmacology (6 papers). Corinna Hahn‐Ast collaborates with scholars based in Germany, United Kingdom and Switzerland. Corinna Hahn‐Ast's co-authors include Axel Glasmacher, Marie von Lilienfeld‐Toal, G. Marklein, Katjana Orlopp, Gordon Cook, M von Lilienfeld-Toal, Frank Stüber, Ingvill Purr, Peter Brossart and A. Schmitz and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Corinna Hahn‐Ast

22 papers receiving 481 citations

Peers

Corinna Hahn‐Ast

ONCOL

EPIDE

HEMAT

Ola Blennow Sweden

Clara Minotti Italy

Christian Kjellander Sweden

M Buelli Italy

Riva Fineman Israel

Adam J. DiPippo United States

Gilhen Rodriguez United States

Ja Young Seo South Korea

Hubert Szelényi Germany

Pascale Frère Belgium

Ola Blennow Sweden

Corinna Hahn‐Ast

268 ×1.3

ONCOL

194 ×1.0

252 ×1.3

EPIDE

127 ×0.9

HEMAT

53 ×0.5

Citations per year, relative to Corinna Hahn‐Ast Corinna Hahn‐Ast (= 1×) peers Ola Blennow

Countries citing papers authored by Corinna Hahn‐Ast

Since Specialization

Citations

This map shows the geographic impact of Corinna Hahn‐Ast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinna Hahn‐Ast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinna Hahn‐Ast more than expected).

Fields of papers citing papers by Corinna Hahn‐Ast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinna Hahn‐Ast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinna Hahn‐Ast. The network helps show where Corinna Hahn‐Ast may publish in the future.

Co-authorship network of co-authors of Corinna Hahn‐Ast

This figure shows the co-authorship network connecting the top 25 collaborators of Corinna Hahn‐Ast. A scholar is included among the top collaborators of Corinna Hahn‐Ast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinna Hahn‐Ast. Corinna Hahn‐Ast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mayer, Karin, et al.. (2023). Treatment of acute myeloid leukaemia in older patients – scope of intensive therapy? – A retrospective analysis. Hematology. 28(1). 2212536–2212536. 1 indexed citations

Mayer, Karin, et al.. (2022). COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA. Mediterranean Journal of Hematology and Infectious Diseases. 14(1). e2022032–e2022032. 3 indexed citations

Mayer, Karin, Corinna Hahn‐Ast, Katjana Schwab, et al.. (2020). Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review. European Journal Of Haematology. 104(6). 538–545. 5 indexed citations

Hahn‐Ast, Corinna, Karin Mayer, Markus Ruhnke, et al.. (2016). Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia. Annals of Hematology. 95(6). 1001–1009. 6 indexed citations

Mayer, Karin, Corinna Hahn‐Ast, Andrea Schmitz, et al.. (2015). Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia. Supportive Care in Cancer. 23(5). 1321–1329. 4 indexed citations

Hahn‐Ast, Corinna, et al.. (2014). Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment. Annals of Hematology. 93(12). 1993–1999. 10 indexed citations

Schwab, Katjana, Corinna Hahn‐Ast, Werner Heinz, et al.. (2013). Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals. Infection. 42(1). 97–104. 13 indexed citations

Langer, Christian, et al.. (2012). Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers. Clinical Lymphoma Myeloma & Leukemia. 12(3). 191–196. 21 indexed citations

Hahn‐Ast, Corinna, et al.. (2012). Lenalidomide in Relapsed and Refractory Multiple Myeloma Disease: Feasibility and Benefits of Long-Term Treatment. Blood. 120(21). 4069–4069. 4 indexed citations

10.

Hahn‐Ast, Corinna. (2010). Improved progression-free survival and overall survival with thalidomide maintenance therapy in multiple myeloma : a meta-analysis of randomized trials in 2274 patients. Haematologica. 95(2). 391. 12 indexed citations

11.

Hahn‐Ast, Corinna, Axel Glasmacher, A. Schmitz, et al.. (2010). Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. Journal of Antimicrobial Chemotherapy. 65(4). 761–768. 80 indexed citations

12.

Lilienfeld‐Toal, Marie von, Lutz Lehmann, Ansgar Raadts, et al.. (2009). Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile Neutropenia. Journal of Clinical Microbiology. 47(8). 2405–2410. 108 indexed citations

13.

Lilienfeld-Toal, M von, Corinna Hahn‐Ast, Florian Hoffmann, et al.. (2008). A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma. European Journal Of Haematology. 81(4). 247–252. 56 indexed citations

14.

Gorschlüter, Marcus, Volker Schmitz, Ulrich Mey, et al.. (2008). Endoscopy in patients with acute leukaemia after intensive chemotherapy. Leukemia Research. 32(10). 1510–1517. 13 indexed citations

15.

Orlopp, Katjana, M von Lilienfeld-Toal, G. Marklein, et al.. (2008). False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?. Journal of Antimicrobial Chemotherapy. 62(5). 1109–1112. 22 indexed citations

16.

Hahn‐Ast, Corinna, Axel Glasmacher, Andreas Mühling, et al.. (2008). An Audit of Efficacy and Toxicity of Teicoplanin Versus Vancomycin in Febrile Neutropenia: Is the Different Toxicity Profile Clinically Relevant?. Infection. 36(1). 54–58. 17 indexed citations

17.

Lilienfeld-Toal, M von, Corinna Hahn‐Ast, H. Kirchner, et al.. (2007). A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy. Haematologica. 92(12). 1719–1720. 8 indexed citations

18.

Schmidt‐Wolf, Ingo, Axel Glasmacher, Corinna Hahn‐Ast, et al.. (2006). Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Cancer Genetics and Cytogenetics. 167(1). 20–25. 19 indexed citations

19.

Lilienfeld‐Toal, Marie von, Anja Schneider, Katjana Orlopp, et al.. (2006). Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Supportive Care in Cancer. 14(12). 1241–1245. 19 indexed citations

20.

Schmidt‐Wolf, Ingo, Thomas Moehler, Hartmut Goldschmidt, et al.. (2006). Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.. Blood. 108(11). 3559–3559. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact